Publication | Open Access
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer
32
Citations
21
References
2017
Year
The present study suggests that silybin in combination with regorafenib is a promising strategy for treatment of metastatic colorectal patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1